Kieran Gallahue's Trading History
| NVSTEnvista Holdings | May 21, 2026 | Director | Uninformative Buy | ― | $1.27M | |
| EWEdwards Lifesciences | May 08, 2026 | Director | Uninformative Buy | ― | $7.73M | |
| XENTIntersect ENT | May 16, 2022 | ― | Uninformative Sell | 968.21K | $0.00 | |
| ARNAArena Pharma | Mar 11, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| CFNCarefusion Corp | Mar 19, 2015 | ― | Uninformative Sell | ― | ― | |
| VOLCVolcano Corp | Feb 19, 2015 | ― | Uninformative Sell | 175.28K | ― | |
| RMDResmed | Jan 07, 2011 | CEO, Director | Informative Sell | 1.14M | $13.09M |
You May Also Like
Kieran Gallahue insider profile FAQ
What is the percentage of profitable transactions made by Kieran Gallahue?
The percentage of profitable transactions made by Kieran Gallahue is 100%.
What is the average return per transaction made by Kieran Gallahue?
The average return per transaction made by Kieran Gallahue is 41.50%.
What stocks does Kieran Gallahue hold?
Kieran Gallahue holds: NVST, ARNA, CFN, EW, VOLC, XENT, RMD stocks.
What was Kieran Gallahue's most profitable transaction?
Kieran Gallahue’s most profitable transaction was an Informative Buy of XENT stock on May 17, 2016. The return on the trade was 77.40%.
What is Kieran Gallahue's role in Envista Holdings?
Kieran Gallahue's role in Envista Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.